FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 137 filers reported holding FLEXION THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $3,129,000 | -26.3% | 512,747 | -0.7% | 0.00% | 0.0% |
Q2 2021 | $4,248,000 | -5.3% | 516,160 | +2.9% | 0.00% | 0.0% |
Q1 2021 | $4,488,000 | -27.7% | 501,456 | -6.8% | 0.00% | 0.0% |
Q4 2020 | $6,208,000 | +6.9% | 537,985 | -3.5% | 0.00% | 0.0% |
Q3 2020 | $5,806,000 | -10.9% | 557,690 | +12.5% | 0.00% | -50.0% |
Q2 2020 | $6,518,000 | +85.0% | 495,697 | +10.7% | 0.00% | +100.0% |
Q1 2020 | $3,524,000 | -61.8% | 447,849 | +0.4% | 0.00% | -50.0% |
Q4 2019 | $9,230,000 | +46.3% | 445,895 | -3.2% | 0.00% | 0.0% |
Q3 2019 | $6,311,000 | +14.3% | 460,489 | +2.6% | 0.00% | +100.0% |
Q2 2019 | $5,522,000 | -1.1% | 448,993 | +0.3% | 0.00% | 0.0% |
Q1 2019 | $5,584,000 | +10.1% | 447,464 | -0.1% | 0.00% | 0.0% |
Q4 2018 | $5,073,000 | -42.0% | 448,080 | -4.2% | 0.00% | -50.0% |
Q3 2018 | $8,751,000 | -25.8% | 467,703 | +2.6% | 0.00% | -33.3% |
Q2 2018 | $11,790,000 | +23.4% | 456,053 | +6.9% | 0.00% | +50.0% |
Q1 2018 | $9,558,000 | -9.3% | 426,469 | +1.3% | 0.00% | -33.3% |
Q4 2017 | $10,542,000 | +20.6% | 421,018 | +16.5% | 0.00% | +50.0% |
Q3 2017 | $8,738,000 | +17.6% | 361,349 | -1.6% | 0.00% | 0.0% |
Q2 2017 | $7,428,000 | -20.1% | 367,372 | +6.4% | 0.00% | -33.3% |
Q1 2017 | $9,291,000 | +44.2% | 345,265 | +2.0% | 0.00% | +50.0% |
Q4 2016 | $6,442,000 | +15.9% | 338,642 | +19.0% | 0.00% | 0.0% |
Q3 2016 | $5,558,000 | +56.2% | 284,460 | +19.6% | 0.00% | +100.0% |
Q2 2016 | $3,559,000 | +136.8% | 237,786 | +45.5% | 0.00% | – |
Q1 2016 | $1,503,000 | -58.1% | 163,423 | -12.3% | 0.00% | -100.0% |
Q4 2015 | $3,590,000 | +38.9% | 186,300 | +7.1% | 0.00% | 0.0% |
Q3 2015 | $2,585,000 | +44.7% | 173,934 | +113.0% | 0.00% | 0.0% |
Q2 2015 | $1,787,000 | +8.4% | 81,646 | +11.5% | 0.00% | – |
Q1 2015 | $1,649,000 | +32.8% | 73,240 | +19.0% | 0.00% | – |
Q4 2014 | $1,242,000 | +34.6% | 61,521 | +21.6% | 0.00% | – |
Q3 2014 | $923,000 | +40.3% | 50,587 | +3.7% | 0.00% | – |
Q2 2014 | $658,000 | +93.0% | 48,790 | +135.8% | 0.00% | – |
Q1 2014 | $341,000 | – | 20,694 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |